For decades, America’s drug-price debate has centered on a fundamental tension: How do policymakers encourage expensive research and development, while ensuring that companies keep final prices ...

President Trump proposed a plan to lower prescription drug prices, focusing on the "Most Favored Nation" executive order. The plan aims to address the disparity in drug prices between the U.S. and ...

The high cost of prescription drugs in America has again moved back into the political spotlight, with President Trump recently signing an executive order aimed at bringing prices more in line with ...

The authors argue that sustainable drug pricing reform should focus on patient-centered value, not price alone. IRP is a ...

Forbes contributors publish independent expert analyses and insights. Sally Pipes is a scholar and think tank CEO who writes on health care. President Trump is also looking to revive some of the ...

President Donald Trump is ramping up the heat on pharmaceutical companies, urging them in letters sent Thursday to cut down drug prices in accordance with an executive order he signed in May. But ...

Approximately 3.2 million Americans suffering from cancer, heart disease, and other serious or life-threatening diseases benefit from home infusion therapy. As the name suggests, home infusion therapy ...

In May, President Donald Trump signed an executive order to combat high drug prices by establishing a most-favored nation policy. The president is correct to seek to lower drug prices, as the U.S. has ...

The MFN executive order seeks to align US drug prices with those in other developed countries, recently advancing through a voluntary agreement with Pfizer. Legal and procedural challenges exist, with ...

President Donald Trump signs an executive order on Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients at a press conference with Health and Human Services Secretary Robert F ...